Merck Stock
Merck KGaA
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Germany
- CEO
- Kai Beckmann
- Employees
- 62,136
- Market cap
- €62.7 B
- IPO
- 26/06/1998
Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and…
Merck stock: price history
1D
+0.7%
1W
+4.7%
1M
+9.6%
6M
+21.8%
YTD
+17.7%
1Y
+29.0%
2Y
-6.4%
5Y
-25.0%
10Y
+45.9%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~29% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Merck stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Merck KGaA is a diversified science and technology company operating in three core segments: Life Science, Healthcare, and Electronics. In the Life Science area, the company provides tools, chemicals, and equipment for research as well as services for process development. The Healthcare segment covers the entire lifecycle of therapeutics, with a focus on oncology, neurology, and immunology. The Electronics division supplies highly specialized materials for the semiconductor and display industries as well as solutions in surface design. The business model is characterized by a combination of the sale of chemical and pharmaceutical products as well as technical expertise and scientific services across various industries.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Regulatory
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Merck
Merck stock metrics
P/E
26.48
P/B
2.08
EV/EBITDA
11.53
RETURN ON EQUITY
1.6%
NET MARGIN
9.0%
DEBT/EQUITY
0.41
DIVIDEND YIELD
1.5%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
434,774,828
AVG. DAILY VOLUME (30D)
293,218
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Merck stock
What does Merck do?
Merck KGaA is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Germany.
The CEO is Kai Beckmann, the company employs around 62,136 people.
The IPO was on 26/06/1998; the stock trades on XETRA under the ticker MRK.DE.
When does Merck report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 29% stronger than usual.
Does Merck pay a dividend?
Yes. The last dividend was €2.20 per share, ex-date 27/04/2026, paid on 29/04/2026.
The dividend yield is 1.5% (as of 30/06/2026).
Which stocks are comparable to Merck?
Comparable stocks include Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings, Amneal Pharmaceuticals and Indivior Pharmaceuticals.
How can I get Merck stock analyzed?
Clicking "Analyze stock" lets five strategies assess Merck against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.